Oculis Holding AG (OCS) Non-Current Deferred Tax Liability (2021)

Oculis Holding AG (OCS) posted quarterly Non-Current Deferred Tax Liability of $11929.5 for Q4 2021.

Oculis Holding AG (OCS) Non-Current Deferred Tax Liability (2021) Analysis & Trends

Oculis Holding AG's Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $11929.5 for Q4 2021.

In Q4 2021, Non-Current Deferred Tax Liability changed N/A year-over-year to $11929.5; the TTM figure through Dec 2021 stood at $11929.5 (changed N/A YoY), while the FY2021 annual figure was $12037.8, changed N/A from the prior year.
Non-Current Deferred Tax Liability for Q4 2021 stood at $11929.5.
The five-year high for Non-Current Deferred Tax Liability was $11929.5 in Q4 2021, with the low at $11929.5 in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Oculis Holding AG	879.09 Mn	590.21 Mn	-

Download Data

Date	Value
Dec 31, 2021	11,929.52
Dec 31, 2021	11,929.52